Literature DB >> 16612284

Elicited antibodies in baboons exposed to tissues from alpha1,3-galactosyltransferase gene-knockout pigs.

Yau-Lin Tseng1, Kathleen Moran, Frank J M F Dor, Todd M Sanderson, Wei Li, Courtney J Lancos, Henk-Jan Schuurman, David H Sachs, David K C Cooper.   

Abstract

BACKGROUND: This study investigates anti-nonGal antibodies (Abs) in baboons after alpha1,3-galactosyltransferase gene-knockout (GalT-KO) pig heart transplantation (Tx).
METHODS: Four baboons underwent pig heart Tx under chronic immunosuppression, which was discontinued after graftectomy. During follow-up, one baboon also received a pig splenocyte infusion. Hearts and splenocytes were from GalT-KO pigs (n = 3) or pigs with low Gal expression (Gal-low, n = 2), all of swine leukocyte antigen (SLA) dd haplotype. Several weeks after graftectomy, sera were tested by flow cytometry and cytotoxicity assay on porcine peripheral blood mononuclear cells (PBMC) for elicited anti-nonGal Abs. Sera were adsorbed on a Gal immunoaffinity matrix, and tested for SLA haplotype specificity using PBMC from SLA aa, cc, and dd haplotypes.
RESULTS: Before heart Tx, no baboon had anti-nonGal Abs demonstrable by binding or cytotoxicity to GalT-KO PBMC. All four baboons developed anti-nonGal Abs after Tx, demonstrable by flow cytometry, and three sera from baboons showed cytotoxicity to GalT-KO PBMC of SLA(dd) haplotype. After adsorption of anti-Gal Abs, the elicited anti-nonGal Abs showed similar binding to PBMCs from pigs of all three haplotypes (SLA(dd), SLA(aa), SLA(cc)).
CONCLUSIONS: Anti-nonGal Abs developed after GalT-KO pig heart Tx into baboons. The most potent of these antibodies appeared to detect antigens shared by the three pig haplotypes tested. It remains unclear whether these antibodies are directed towards shared SLA determinants or other pig antigens, and whether antibodies with specificity for allelic SLA determinants are also present, but at lower titer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612284     DOI: 10.1097/01.tp.0000197555.16093.98

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  B-cell depletion extends the survival of GTKO.hCD46Tg pig heart xenografts in baboons for up to 8 months.

Authors:  M M Mohiuddin; P C Corcoran; A K Singh; A Azimzadeh; R F Hoyt; M L Thomas; M A Eckhaus; C Seavey; D Ayares; R N Pierson; K A Horvath
Journal:  Am J Transplant       Date:  2011-11-09       Impact factor: 8.086

2.  The utility of right ventricular endomyocardial biopsy for the diagnosis of xenograft rejection after CD46 pig-to-baboon cardiac transplantation.

Authors:  Davide Ricci; Henry D Tazelaar; Naoto Miyagi; Vinay P Rao; Rachel A Pedersen; Walter K Kremers; Guerard W Byrne; Christopher G A McGregor
Journal:  J Heart Lung Transplant       Date:  2007-10       Impact factor: 10.247

Review 3.  Porcine embryonic stem cells: a possible source for cell replacement therapy.

Authors:  Vanessa Hall
Journal:  Stem Cell Rev       Date:  2008-12       Impact factor: 5.739

4.  Proteomic identification of non-Gal antibody targets after pig-to-primate cardiac xenotransplantation.

Authors:  Guerard W Byrne; Paul G Stalboerger; Eduardo Davila; Carrie J Heppelmann; Mozammel H Gazi; Hugh C J McGregor; Peter T LaBreche; William R Davies; Vinay P Rao; Keiji Oi; Henry D Tazelaar; John S Logan; Christopher G A McGregor
Journal:  Xenotransplantation       Date:  2008 Jul-Aug       Impact factor: 3.907

5.  Up to 9-day survival and control of thrombocytopenia following alpha1,3-galactosyl transferase knockout swine liver xenotransplantation in baboons.

Authors:  Karen Kim; Christian Schuetz; Nahel Elias; Gregory R Veillette; Isaac Wamala; Manish Varma; R Neal Smith; Simon C Robson; A Benedict Cosimi; David H Sachs; Martin Hertl
Journal:  Xenotransplantation       Date:  2012 Jul-Aug       Impact factor: 3.907

6.  Development of a consensus protocol to quantify primate anti-non-Gal xenoreactive antibodies using pig aortic endothelial cells.

Authors:  Agnes M Azimzadeh; Guerard W Byrne; Mohamed Ezzelarab; Emily Welty; Gheorghe Braileanu; Xiangfei Cheng; Simon C Robson; Christopher G A McGregor; David K C Cooper; Richard N Pierson
Journal:  Xenotransplantation       Date:  2014-09-01       Impact factor: 3.907

7.  Induction of human T-cell tolerance to pig xenoantigens via thymus transplantation in mice with an established human immune system.

Authors:  K Habiro; M Sykes; Y-G Yang
Journal:  Am J Transplant       Date:  2009-05-20       Impact factor: 8.086

8.  High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.

Authors:  Fabienne Haspot; Philip D Bardwell; Guiling Zhao; Megan Sykes
Journal:  Xenotransplantation       Date:  2008 Sep-Oct       Impact factor: 3.907

Review 9.  Current status of islet cell transplantation.

Authors:  Hirohito Ichii; Camillo Ricordi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-12-26

Review 10.  Current status of xenotransplantation and prospects for clinical application.

Authors:  Richard N Pierson; Anthony Dorling; David Ayares; Michael A Rees; Jörg D Seebach; Jay A Fishman; Bernhard J Hering; David K C Cooper
Journal:  Xenotransplantation       Date:  2009 Sep-Oct       Impact factor: 3.907

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.